Market Overview

US Stock Futures Up; All Eyes On Jobs Report

Share:
US Stock Futures Up; All Eyes On Jobs Report
Related NVS
Canaccord Slices Regeneron Price Target 32% On Eylea, Dupixent Challenges
Wedbush: Restorbio's Therapy For Aging-Related Diseases Has Best-In-Class Potential
Your Daily Pharma Scoop: Dynavax Achieves Major Milestone, GW Pharmaceuticals GWP42006 Fails, Sangamo Signs Deal With Gilead's Kite Unit (Seeking Alpha)
Related AMGN
The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease
Benzinga's Top Upgrades, Downgrades For February 5, 2018
Amgen: Outlook (Seeking Alpha)

Pre-open movers

US stock futures traded higher in early pre-market trade. Data on non-farm payrolls for September will be released at 8:30 a.m. ET, while factory orders data for August will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 55.5 points to 16,245.5, while the Standard & Poor's 500 index futures rose 6 points to 1,922.75. Futures for the Nasdaq 100 index surged 19.75 points to 4,207.25.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index gaining 1.03 percent, STOXX Europe 600 Index jumping 1.52 percent and German DAX 30 index gaining 1.46 percent. French CAC 40 Index rose 1.80 percent and London's FTSE 100 Index rose 1.55 percent.

In Asian markets, Japan's Nikkei Stock Average rose 0.02 percent and Hong Kong's Hang Seng Index gained 3.17 percent.

Broker Recommendation
Analysts at Oppenheimer upgraded Google Inc (NASDAQ: GOOG) from Perform to Outperform and raised the price target from $670.00 to $700.00.

Google shares rose 0.80 percent to $616.16 in pre-market trading.

Breaking news

  • Sandoz, a Novartis AG (ADR) (NYSE: NVS) company and the global leader in biosimilars, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen, Inc.'s (NASDAQ: AMGN) US-licensed Enbrel®* (etanercept) - a tumor necrosis factor alpha (TNF-alpha) inhibitor. To read the full news, click here.
  • Applied Industrial Technologies (NYSE: AIT) today announced it has acquired S. G. Morris Co. (SGM), a distributor of fluid power components and provider of engineered fluid power systems. To read the full news, click here.
  • Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected earnings for its fiscal fourth quarter on Thursday. To read the full news, click here.
  • Progress Software Corporation (NASDAQ: PRGS) reported stronger-than-expected earnings for its fiscal third quarter. However, the company reported downbeat quarterly revenue and lowered its revenue forecast for the full year. To read the full news, click here.

Posted-In: Oppenheimer US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (AMGN + AIT)

View Comments and Join the Discussion!